 Denis Bensard
Concepts (549)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds, Nonpenetrating | 34 | 2022 | 278 | 7.560 |
Why?
| | Wounds and Injuries | 23 | 2025 | 758 | 4.940 |
Why?
| | Trauma Centers | 39 | 2023 | 421 | 4.390 |
Why?
| | Shock | 9 | 2025 | 98 | 3.860 |
Why?
| | Injury Severity Score | 44 | 2023 | 522 | 3.670 |
Why?
| | Abdominal Injuries | 13 | 2022 | 123 | 2.990 |
Why?
| | Blood Transfusion | 17 | 2022 | 325 | 2.880 |
Why?
| | Shock, Hemorrhagic | 6 | 2021 | 167 | 2.330 |
Why?
| | Glasgow Coma Scale | 8 | 2023 | 186 | 2.140 |
Why?
| | Wounds, Penetrating | 4 | 2023 | 65 | 1.870 |
Why?
| | Triage | 9 | 2025 | 222 | 1.780 |
Why?
| | Spleen | 7 | 2021 | 514 | 1.640 |
Why?
| | Craniocerebral Trauma | 6 | 2022 | 170 | 1.590 |
Why?
| | Child | 99 | 2025 | 21935 | 1.550 |
Why?
| | Brain Injuries | 9 | 2015 | 494 | 1.530 |
Why?
| | Blood Coagulation Disorders | 5 | 2022 | 173 | 1.490 |
Why?
| | Retrospective Studies | 71 | 2023 | 15657 | 1.480 |
Why?
| | Thoracic Injuries | 4 | 2018 | 55 | 1.440 |
Why?
| | Thoracotomy | 8 | 2020 | 75 | 1.410 |
Why?
| | Blood Component Transfusion | 3 | 2022 | 84 | 1.310 |
Why?
| | Child, Preschool | 60 | 2023 | 11074 | 1.190 |
Why?
| | Thrombelastography | 5 | 2022 | 154 | 1.160 |
Why?
| | Liver | 9 | 2021 | 1943 | 1.120 |
Why?
| | Tomography, X-Ray Computed | 15 | 2022 | 2691 | 1.120 |
Why?
| | Laparoscopy | 11 | 2015 | 466 | 1.100 |
Why?
| | Appendicitis | 7 | 2021 | 130 | 1.010 |
Why?
| | Adolescent | 64 | 2023 | 21513 | 0.990 |
Why?
| | Resuscitation | 5 | 2022 | 251 | 0.980 |
Why?
| | Appendectomy | 6 | 2021 | 79 | 0.960 |
Why?
| | Emergency Service, Hospital | 8 | 2023 | 2069 | 0.950 |
Why?
| | Hematocrit | 2 | 2015 | 96 | 0.900 |
Why?
| | Infant | 46 | 2023 | 9465 | 0.870 |
Why?
| | Emergency Medical Services | 3 | 2023 | 552 | 0.830 |
Why?
| | Erythrocyte Transfusion | 3 | 2022 | 194 | 0.810 |
Why?
| | Decision Support Techniques | 4 | 2022 | 421 | 0.800 |
Why?
| | Humans | 135 | 2025 | 137585 | 0.780 |
Why?
| | Child Abuse | 6 | 2014 | 535 | 0.780 |
Why?
| | Severity of Illness Index | 4 | 2019 | 2828 | 0.780 |
Why?
| | Heart Rate | 6 | 2023 | 822 | 0.770 |
Why?
| | Length of Stay | 13 | 2022 | 1215 | 0.760 |
Why?
| | Risk Adjustment | 1 | 2022 | 78 | 0.720 |
Why?
| | Early Medical Intervention | 1 | 2022 | 57 | 0.720 |
Why?
| | Male | 98 | 2022 | 67762 | 0.700 |
Why?
| | Blood Pressure | 7 | 2023 | 1786 | 0.680 |
Why?
| | Radiation Exposure | 1 | 2020 | 49 | 0.650 |
Why?
| | Intubation, Gastrointestinal | 3 | 2020 | 79 | 0.640 |
Why?
| | Hypotension | 3 | 2016 | 122 | 0.610 |
Why?
| | Patient Selection | 2 | 2022 | 696 | 0.600 |
Why?
| | Female | 76 | 2022 | 73304 | 0.600 |
Why?
| | Enteral Nutrition | 2 | 2020 | 202 | 0.590 |
Why?
| | Pylorus | 2 | 2010 | 18 | 0.590 |
Why?
| | Pyloric Stenosis, Hypertrophic | 2 | 2010 | 10 | 0.580 |
Why?
| | Catheterization, Central Venous | 2 | 2018 | 112 | 0.580 |
Why?
| | Hospitals, Pediatric | 4 | 2018 | 508 | 0.570 |
Why?
| | Lung Diseases | 7 | 2022 | 767 | 0.570 |
Why?
| | Colorado | 25 | 2022 | 4565 | 0.550 |
Why?
| | Head Injuries, Closed | 3 | 2012 | 48 | 0.510 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 360 | 0.510 |
Why?
| | Bicycling | 1 | 2017 | 114 | 0.500 |
Why?
| | Bacteremia | 1 | 2018 | 214 | 0.500 |
Why?
| | Hemoglobins | 3 | 2022 | 353 | 0.490 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2015 | 5 | 0.490 |
Why?
| | Gastrostomy | 2 | 2015 | 117 | 0.490 |
Why?
| | Intestinal Volvulus | 1 | 2015 | 22 | 0.470 |
Why?
| | Thrombosis | 1 | 2018 | 371 | 0.460 |
Why?
| | Rehydration Solutions | 1 | 2014 | 8 | 0.460 |
Why?
| | Lung | 14 | 2022 | 4060 | 0.460 |
Why?
| | Isotonic Solutions | 1 | 2014 | 38 | 0.450 |
Why?
| | Shock, Traumatic | 1 | 2014 | 14 | 0.450 |
Why?
| | Infant, Newborn | 17 | 2020 | 6079 | 0.430 |
Why?
| | Multiple Trauma | 7 | 2014 | 100 | 0.430 |
Why?
| | Preoperative Care | 2 | 2015 | 362 | 0.430 |
Why?
| | Vascular System Injuries | 3 | 2021 | 71 | 0.410 |
Why?
| | Age Factors | 9 | 2025 | 3295 | 0.400 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 234 | 0.400 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2013 | 92 | 0.390 |
Why?
| | Critical Illness | 1 | 2018 | 811 | 0.390 |
Why?
| | Laparotomy | 7 | 2023 | 109 | 0.390 |
Why?
| | Acidosis | 1 | 2013 | 101 | 0.390 |
Why?
| | Tracheostomy | 1 | 2014 | 133 | 0.380 |
Why?
| | Risk Assessment | 4 | 2021 | 3457 | 0.380 |
Why?
| | Referral and Consultation | 1 | 2018 | 786 | 0.380 |
Why?
| | Sensitivity and Specificity | 6 | 2022 | 1946 | 0.380 |
Why?
| | Risk Factors | 14 | 2022 | 10388 | 0.370 |
Why?
| | Prognosis | 10 | 2023 | 4030 | 0.370 |
Why?
| | Registries | 11 | 2021 | 2035 | 0.360 |
Why?
| | Spinal Cord Injuries | 2 | 2014 | 212 | 0.350 |
Why?
| | Treatment Outcome | 18 | 2020 | 10811 | 0.320 |
Why?
| | Mass Screening | 2 | 2019 | 1287 | 0.290 |
Why?
| | Viscera | 2 | 2005 | 17 | 0.280 |
Why?
| | Critical Pathways | 1 | 2009 | 96 | 0.280 |
Why?
| | Wounds, Gunshot | 2 | 2022 | 228 | 0.280 |
Why?
| | Lipopolysaccharides | 10 | 2004 | 886 | 0.270 |
Why?
| | Thoracoscopy | 4 | 2006 | 56 | 0.270 |
Why?
| | Accidents, Home | 2 | 2004 | 31 | 0.260 |
Why?
| | Endotoxins | 7 | 1999 | 220 | 0.250 |
Why?
| | Adult | 30 | 2022 | 37929 | 0.250 |
Why?
| | Pyelonephritis, Xanthogranulomatous | 1 | 2006 | 2 | 0.250 |
Why?
| | Radiation Dosage | 2 | 2020 | 179 | 0.240 |
Why?
| | Heart Arrest | 3 | 2018 | 339 | 0.240 |
Why?
| | Survival Rate | 8 | 2016 | 1972 | 0.240 |
Why?
| | Surgeons | 2 | 2021 | 297 | 0.230 |
Why?
| | Digestive System Surgical Procedures | 1 | 2005 | 106 | 0.220 |
Why?
| | Follow-Up Studies | 9 | 2022 | 5131 | 0.220 |
Why?
| | Receptors, Adrenergic, beta | 3 | 1994 | 127 | 0.220 |
Why?
| | Leg Injuries | 1 | 2004 | 25 | 0.220 |
Why?
| | Neutrophils | 13 | 2002 | 1238 | 0.210 |
Why?
| | Incidence | 11 | 2020 | 2804 | 0.210 |
Why?
| | Surgical Wound | 1 | 2023 | 23 | 0.200 |
Why?
| | Anticoagulants | 3 | 2019 | 664 | 0.200 |
Why?
| | Intestines | 2 | 2004 | 357 | 0.190 |
Why?
| | Precipitating Factors | 1 | 2022 | 6 | 0.190 |
Why?
| | Pediatric Emergency Medicine | 1 | 2022 | 24 | 0.190 |
Why?
| | Enterocolitis, Neutropenic | 1 | 2021 | 6 | 0.180 |
Why?
| | False Positive Reactions | 1 | 2022 | 115 | 0.180 |
Why?
| | Intracranial Pressure | 1 | 2022 | 49 | 0.180 |
Why?
| | Heart Injuries | 1 | 2021 | 37 | 0.180 |
Why?
| | Fundoplication | 2 | 2015 | 53 | 0.180 |
Why?
| | Hypovolemia | 1 | 2021 | 10 | 0.180 |
Why?
| | Logistic Models | 3 | 2016 | 2074 | 0.170 |
Why?
| | Jejunostomy | 1 | 2020 | 13 | 0.170 |
Why?
| | Intraoperative Complications | 1 | 2022 | 138 | 0.170 |
Why?
| | Time Factors | 10 | 2014 | 6828 | 0.170 |
Why?
| | Early Diagnosis | 1 | 2022 | 242 | 0.170 |
Why?
| | Postoperative Care | 3 | 2019 | 261 | 0.170 |
Why?
| | Frailty | 1 | 2023 | 170 | 0.170 |
Why?
| | Stomach | 1 | 2020 | 110 | 0.160 |
Why?
| | Plasma | 1 | 2022 | 212 | 0.160 |
Why?
| | Prospective Studies | 7 | 2022 | 7604 | 0.160 |
Why?
| | Hospital Mortality | 2 | 2014 | 911 | 0.160 |
Why?
| | Respiration, Artificial | 3 | 2014 | 645 | 0.160 |
Why?
| | Cerebrovascular Trauma | 1 | 2019 | 17 | 0.160 |
Why?
| | Salmonella typhimurium | 6 | 2002 | 183 | 0.160 |
Why?
| | Heart | 2 | 1994 | 655 | 0.160 |
Why?
| | Mortality | 1 | 2022 | 362 | 0.150 |
Why?
| | Phlebotomy | 1 | 2019 | 21 | 0.150 |
Why?
| | Monitoring, Physiologic | 1 | 2021 | 275 | 0.150 |
Why?
| | Diagnosis, Differential | 5 | 2014 | 1483 | 0.150 |
Why?
| | Firearms | 2 | 2022 | 386 | 0.150 |
Why?
| | Central Venous Catheters | 1 | 2018 | 51 | 0.150 |
Why?
| | Isoproterenol | 4 | 1998 | 113 | 0.140 |
Why?
| | Platelet Activating Factor | 3 | 1992 | 76 | 0.140 |
Why?
| | Trauma Severity Indices | 4 | 2013 | 106 | 0.140 |
Why?
| | Feasibility Studies | 1 | 2022 | 956 | 0.140 |
Why?
| | Cholestasis | 1 | 2000 | 235 | 0.140 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2015 | 249 | 0.140 |
Why?
| | Stroke | 2 | 2019 | 1120 | 0.140 |
Why?
| | Colforsin | 4 | 2001 | 53 | 0.140 |
Why?
| | Abdomen, Acute | 1 | 1997 | 21 | 0.140 |
Why?
| | Patient Readmission | 2 | 2020 | 697 | 0.130 |
Why?
| | Hospitalization | 4 | 2016 | 2199 | 0.130 |
Why?
| | Algorithms | 2 | 2021 | 1704 | 0.130 |
Why?
| | Health Care Costs | 1 | 2020 | 398 | 0.130 |
Why?
| | Immune System Diseases | 1 | 1997 | 39 | 0.130 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 1079 | 0.130 |
Why?
| | Hospital Charges | 1 | 2016 | 44 | 0.130 |
Why?
| | United States | 7 | 2022 | 14841 | 0.130 |
Why?
| | Surgery Department, Hospital | 1 | 2016 | 20 | 0.130 |
Why?
| | Hospital Rapid Response Team | 1 | 2016 | 19 | 0.130 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3284 | 0.130 |
Why?
| | Myocardial Reperfusion Injury | 4 | 1992 | 135 | 0.130 |
Why?
| | Cause of Death | 2 | 2014 | 434 | 0.120 |
Why?
| | Intensive Care Units | 1 | 2022 | 827 | 0.120 |
Why?
| | Hemostatic Techniques | 1 | 2016 | 46 | 0.120 |
Why?
| | Chemokines | 3 | 2001 | 228 | 0.120 |
Why?
| | Exsanguination | 2 | 2012 | 19 | 0.120 |
Why?
| | Multiple Organ Failure | 4 | 2003 | 128 | 0.120 |
Why?
| | Medical Futility | 1 | 2015 | 23 | 0.120 |
Why?
| | Funnel Chest | 2 | 2005 | 27 | 0.120 |
Why?
| | Splenectomy | 1 | 2015 | 62 | 0.120 |
Why?
| | Intestine, Small | 1 | 1996 | 156 | 0.120 |
Why?
| | Research Design | 1 | 2022 | 1139 | 0.120 |
Why?
| | Specialization | 1 | 2016 | 144 | 0.110 |
Why?
| | Arterial Occlusive Diseases | 1 | 1995 | 83 | 0.110 |
Why?
| | Critical Care | 3 | 2013 | 601 | 0.110 |
Why?
| | Ultrasonography | 4 | 2010 | 759 | 0.110 |
Why?
| | Benchmarking | 1 | 2016 | 186 | 0.110 |
Why?
| | Accidents | 1 | 2014 | 37 | 0.110 |
Why?
| | Child Advocacy | 1 | 2014 | 32 | 0.110 |
Why?
| | Needs Assessment | 1 | 2016 | 376 | 0.110 |
Why?
| | Intubation, Intratracheal | 1 | 2016 | 257 | 0.110 |
Why?
| | Nervous System Diseases | 1 | 1997 | 266 | 0.110 |
Why?
| | Hemorrhage | 2 | 2016 | 722 | 0.110 |
Why?
| | Macrophages, Peritoneal | 2 | 2004 | 94 | 0.110 |
Why?
| | Craniotomy | 1 | 2014 | 77 | 0.110 |
Why?
| | Rats | 19 | 2002 | 5647 | 0.110 |
Why?
| | Radiography, Thoracic | 2 | 2013 | 167 | 0.110 |
Why?
| | Motor Skills | 1 | 2014 | 97 | 0.100 |
Why?
| | Predictive Value of Tests | 4 | 2013 | 2031 | 0.100 |
Why?
| | Fluid Therapy | 1 | 2014 | 147 | 0.100 |
Why?
| | Tracheotomy | 1 | 2013 | 23 | 0.100 |
Why?
| | Embolization, Therapeutic | 1 | 2015 | 229 | 0.100 |
Why?
| | Contrast Media | 2 | 2015 | 467 | 0.100 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 131 | 0.100 |
Why?
| | Thrombophilia | 1 | 2013 | 83 | 0.100 |
Why?
| | Vascular Surgical Procedures | 2 | 2012 | 303 | 0.100 |
Why?
| | Pandemics | 1 | 2022 | 1639 | 0.100 |
Why?
| | Urinalysis | 1 | 2013 | 77 | 0.100 |
Why?
| | Coronary Disease | 1 | 1995 | 385 | 0.100 |
Why?
| | Postoperative Complications | 6 | 2022 | 2654 | 0.100 |
Why?
| | Unnecessary Procedures | 1 | 2013 | 50 | 0.100 |
Why?
| | Interleukin-10 | 3 | 2004 | 302 | 0.100 |
Why?
| | Blood Group Incompatibility | 1 | 2012 | 15 | 0.100 |
Why?
| | Television | 1 | 1993 | 75 | 0.100 |
Why?
| | Forecasting | 1 | 2014 | 389 | 0.100 |
Why?
| | Electroencephalography | 1 | 2015 | 423 | 0.100 |
Why?
| | Phenytoin | 1 | 2012 | 21 | 0.090 |
Why?
| | Abdominal Wound Closure Techniques | 1 | 2012 | 7 | 0.090 |
Why?
| | Catheter-Related Infections | 1 | 2013 | 92 | 0.090 |
Why?
| | Piracetam | 1 | 2012 | 13 | 0.090 |
Why?
| | Angiography, Digital Subtraction | 1 | 2012 | 44 | 0.090 |
Why?
| | Orthopedic Procedures | 1 | 2014 | 216 | 0.090 |
Why?
| | Patient Education as Topic | 1 | 2016 | 766 | 0.090 |
Why?
| | Chemokines, CXC | 2 | 2002 | 70 | 0.090 |
Why?
| | Vasodilation | 4 | 1999 | 499 | 0.090 |
Why?
| | Surgical Procedures, Operative | 1 | 2014 | 259 | 0.090 |
Why?
| | Neutrophil Infiltration | 2 | 2002 | 107 | 0.090 |
Why?
| | Urinary Tract Infections | 1 | 2013 | 188 | 0.090 |
Why?
| | Thyroidectomy | 1 | 2011 | 106 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 10 | 2002 | 2486 | 0.090 |
Why?
| | Acute Disease | 6 | 2021 | 1007 | 0.080 |
Why?
| | Fat Necrosis | 1 | 1990 | 9 | 0.080 |
Why?
| | Young Adult | 6 | 2022 | 13209 | 0.080 |
Why?
| | Specialties, Surgical | 1 | 2011 | 75 | 0.080 |
Why?
| | Myocardium | 4 | 1993 | 1002 | 0.080 |
Why?
| | Cardiovascular Agents | 1 | 2011 | 159 | 0.080 |
Why?
| | Endocrinology | 1 | 2011 | 79 | 0.080 |
Why?
| | Pericardium | 1 | 1990 | 55 | 0.080 |
Why?
| | Triamcinolone | 1 | 1989 | 17 | 0.080 |
Why?
| | Diaphragm | 2 | 2004 | 42 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1509 | 0.080 |
Why?
| | Chest Pain | 1 | 1990 | 91 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2019 | 1587 | 0.080 |
Why?
| | Consensus | 2 | 2023 | 683 | 0.080 |
Why?
| | Oxygen | 2 | 1994 | 931 | 0.080 |
Why?
| | Anticonvulsants | 1 | 2012 | 217 | 0.080 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2002 | 382 | 0.080 |
Why?
| | Cerebrovascular Circulation | 1 | 2011 | 243 | 0.080 |
Why?
| | Suppuration | 1 | 2009 | 9 | 0.080 |
Why?
| | Esophageal Stenosis | 1 | 1989 | 54 | 0.080 |
Why?
| | Necrosis | 1 | 1990 | 246 | 0.080 |
Why?
| | Perioperative Care | 1 | 2011 | 178 | 0.080 |
Why?
| | Biopsy | 1 | 1993 | 1129 | 0.080 |
Why?
| | Pulmonary Fibrosis | 1 | 1993 | 402 | 0.080 |
Why?
| | General Surgery | 1 | 2011 | 173 | 0.080 |
Why?
| | Aged | 7 | 2023 | 23961 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2004 | 1242 | 0.070 |
Why?
| | Pediatrics | 2 | 2011 | 1101 | 0.070 |
Why?
| | Asparaginase | 2 | 1998 | 30 | 0.070 |
Why?
| | Seizures | 1 | 2012 | 426 | 0.070 |
Why?
| | Accidents, Traffic | 4 | 2011 | 190 | 0.070 |
Why?
| | Pulmonary Artery | 3 | 2000 | 1086 | 0.070 |
Why?
| | Aorta, Thoracic | 2 | 2021 | 267 | 0.070 |
Why?
| | Patient Discharge | 2 | 2016 | 897 | 0.070 |
Why?
| | Cyclic AMP | 2 | 2001 | 234 | 0.070 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2005 | 179 | 0.070 |
Why?
| | Hernia, Inguinal | 2 | 1998 | 36 | 0.070 |
Why?
| | Pancreatitis | 2 | 1998 | 134 | 0.070 |
Why?
| | Pilot Projects | 1 | 2012 | 1710 | 0.070 |
Why?
| | Biliary Atresia | 2 | 2000 | 163 | 0.070 |
Why?
| | Middle Aged | 9 | 2016 | 33479 | 0.060 |
Why?
| | Mediastinal Neoplasms | 1 | 2006 | 45 | 0.060 |
Why?
| | Endotoxemia | 3 | 2002 | 86 | 0.060 |
Why?
| | Hepatic Artery | 1 | 2006 | 62 | 0.060 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2006 | 36 | 0.060 |
Why?
| | Patient Care Team | 1 | 2011 | 631 | 0.060 |
Why?
| | Brachial Plexus | 1 | 2005 | 29 | 0.060 |
Why?
| | Mediastinum | 1 | 2005 | 23 | 0.060 |
Why?
| | Signal Transduction | 2 | 2002 | 5079 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2016 | 1809 | 0.060 |
Why?
| | Rats, Inbred Strains | 8 | 1992 | 362 | 0.060 |
Why?
| | Nevus, Epithelioid and Spindle Cell | 1 | 2005 | 10 | 0.060 |
Why?
| | Neuroblastoma | 1 | 2006 | 160 | 0.060 |
Why?
| | Hospitals, Teaching | 1 | 2005 | 118 | 0.060 |
Why?
| | Kidney | 3 | 2004 | 1468 | 0.060 |
Why?
| | Chemotactic Factors | 2 | 2002 | 56 | 0.060 |
Why?
| | Cohort Studies | 1 | 2015 | 5742 | 0.060 |
Why?
| | Growth Substances | 2 | 2002 | 147 | 0.060 |
Why?
| | Pulmonary Edema | 2 | 2002 | 108 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 740 | 0.060 |
Why?
| | Renal Veins | 1 | 2004 | 19 | 0.060 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2005 | 115 | 0.060 |
Why?
| | Heparin | 2 | 2019 | 261 | 0.060 |
Why?
| | Thoracic Surgical Procedures | 1 | 2005 | 73 | 0.060 |
Why?
| | Renal Artery | 1 | 2004 | 37 | 0.050 |
Why?
| | Leisure Activities | 1 | 2004 | 33 | 0.050 |
Why?
| | Physical Examination | 2 | 2014 | 241 | 0.050 |
Why?
| | Intestinal Perforation | 1 | 2004 | 46 | 0.050 |
Why?
| | Peroxidase | 7 | 2002 | 175 | 0.050 |
Why?
| | Granuloma, Plasma Cell | 1 | 2003 | 13 | 0.050 |
Why?
| | Hernia, Diaphragmatic | 1 | 2003 | 65 | 0.050 |
Why?
| | Age Distribution | 5 | 2003 | 392 | 0.050 |
Why?
| | Twins, Conjoined | 1 | 2003 | 5 | 0.050 |
Why?
| | Pleural Effusion | 1 | 2003 | 54 | 0.050 |
Why?
| | Nephrectomy | 1 | 2004 | 169 | 0.050 |
Why?
| | Rib Fractures | 1 | 2003 | 32 | 0.050 |
Why?
| | Animals | 23 | 2002 | 36940 | 0.050 |
Why?
| | Vital Signs | 1 | 2023 | 43 | 0.050 |
Why?
| | Fluoroscopy | 1 | 2003 | 154 | 0.050 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2022 | 34 | 0.050 |
Why?
| | Anal Canal | 1 | 2003 | 97 | 0.050 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2002 | 22 | 0.050 |
Why?
| | Frail Elderly | 1 | 2023 | 131 | 0.050 |
Why?
| | Chemokine CXCL2 | 4 | 2002 | 43 | 0.050 |
Why?
| | Diseases in Twins | 1 | 2003 | 169 | 0.050 |
Why?
| | Peritonitis | 1 | 2002 | 84 | 0.050 |
Why?
| | Rectum | 1 | 2003 | 185 | 0.050 |
Why?
| | Receptors, Cell Surface | 2 | 2002 | 385 | 0.050 |
Why?
| | Comorbidity | 2 | 2023 | 1622 | 0.040 |
Why?
| | Patients | 1 | 2023 | 175 | 0.040 |
Why?
| | Abnormalities, Multiple | 1 | 2003 | 189 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2001 | 164 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2004 | 513 | 0.040 |
Why?
| | Receptors, Interleukin-1 | 1 | 2002 | 216 | 0.040 |
Why?
| | Pulmonary Circulation | 2 | 1999 | 429 | 0.040 |
Why?
| | Receptors, Chemokine | 1 | 2000 | 47 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2002 | 204 | 0.040 |
Why?
| | Joint Dislocations | 1 | 2000 | 50 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2004 | 965 | 0.040 |
Why?
| | Abbreviated Injury Scale | 1 | 2019 | 22 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2019 | 26 | 0.040 |
Why?
| | Sex Distribution | 4 | 2002 | 375 | 0.040 |
Why?
| | Hydrogen Peroxide | 2 | 1992 | 328 | 0.040 |
Why?
| | Surgical Wound Infection | 1 | 2023 | 307 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2002 | 500 | 0.040 |
Why?
| | Nitric Oxide Synthase | 1 | 2000 | 240 | 0.040 |
Why?
| | Arginine | 1 | 2001 | 271 | 0.040 |
Why?
| | Cervical Vertebrae | 1 | 2000 | 137 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2019 | 121 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2023 | 7635 | 0.040 |
Why?
| | Morbidity | 2 | 2014 | 324 | 0.040 |
Why?
| | Odds Ratio | 1 | 2022 | 1070 | 0.040 |
Why?
| | Salmonella typhi | 1 | 1998 | 13 | 0.040 |
Why?
| | Antigens, CD | 1 | 2001 | 521 | 0.040 |
Why?
| | Hernia, Femoral | 1 | 1998 | 4 | 0.040 |
Why?
| | Receptors, Adrenergic, alpha | 2 | 2000 | 26 | 0.040 |
Why?
| | Edema | 1 | 1999 | 130 | 0.040 |
Why?
| | Monocytes | 1 | 2001 | 563 | 0.040 |
Why?
| | Monokines | 3 | 2002 | 22 | 0.040 |
Why?
| | Melanoma | 1 | 2005 | 760 | 0.040 |
Why?
| | Octreotide | 1 | 1998 | 26 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 1 | 1999 | 115 | 0.040 |
Why?
| | Pneumonia | 1 | 2003 | 639 | 0.030 |
Why?
| | Cecal Diseases | 1 | 1997 | 3 | 0.030 |
Why?
| | Skin Neoplasms | 1 | 2005 | 855 | 0.030 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2011 | 463 | 0.030 |
Why?
| | Aorta | 1 | 2000 | 417 | 0.030 |
Why?
| | Analysis of Variance | 4 | 2004 | 1316 | 0.030 |
Why?
| | Perfusion | 3 | 1992 | 213 | 0.030 |
Why?
| | Survivors | 1 | 2020 | 493 | 0.030 |
Why?
| | Hospitals | 1 | 2021 | 691 | 0.030 |
Why?
| | Leukocyte Count | 2 | 2002 | 329 | 0.030 |
Why?
| | Reoperation | 2 | 2012 | 573 | 0.030 |
Why?
| | Aspirin | 1 | 2019 | 387 | 0.030 |
Why?
| | Portoenterostomy, Hepatic | 1 | 1996 | 46 | 0.030 |
Why?
| | In Vitro Techniques | 3 | 1992 | 1092 | 0.030 |
Why?
| | Abdominal Pain | 1 | 1997 | 145 | 0.030 |
Why?
| | Cystic Duct | 1 | 1996 | 4 | 0.030 |
Why?
| | Hepatic Duct, Common | 1 | 1996 | 6 | 0.030 |
Why?
| | Sepsis | 1 | 2002 | 617 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2016 | 206 | 0.030 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 1996 | 52 | 0.030 |
Why?
| | Recovery of Function | 2 | 2015 | 653 | 0.030 |
Why?
| | Ketone Bodies | 2 | 1992 | 14 | 0.030 |
Why?
| | Receptors, Purinergic P1 | 1 | 1994 | 26 | 0.030 |
Why?
| | Stomach Volvulus | 1 | 1994 | 1 | 0.030 |
Why?
| | Radiography | 3 | 2003 | 822 | 0.030 |
Why?
| | Pneumothorax | 2 | 2005 | 38 | 0.030 |
Why?
| | Disease-Free Survival | 2 | 2006 | 686 | 0.030 |
Why?
| | Ventricular Pressure | 1 | 1994 | 48 | 0.030 |
Why?
| | Tetralones | 1 | 1993 | 4 | 0.030 |
Why?
| | Adenylyl Cyclases | 1 | 1994 | 87 | 0.030 |
Why?
| | Myocardial Reperfusion | 1 | 1993 | 50 | 0.030 |
Why?
| | Administration, Oral | 1 | 2016 | 816 | 0.030 |
Why?
| | Cardiac Output | 1 | 1994 | 165 | 0.030 |
Why?
| | Thoracoscopes | 1 | 1993 | 3 | 0.030 |
Why?
| | Conversion to Open Surgery | 1 | 2013 | 16 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1993 | 180 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2016 | 1236 | 0.020 |
Why?
| | NF-kappa B | 3 | 2001 | 691 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 1998 | 2057 | 0.020 |
Why?
| | Myocardial Contraction | 1 | 1994 | 341 | 0.020 |
Why?
| | Oligopeptides | 2 | 1991 | 271 | 0.020 |
Why?
| | Acetoacetates | 1 | 1992 | 2 | 0.020 |
Why?
| | Surgical Sponges | 1 | 2012 | 4 | 0.020 |
Why?
| | Hydroxybutyrates | 1 | 1992 | 14 | 0.020 |
Why?
| | Cost Control | 1 | 2012 | 39 | 0.020 |
Why?
| | Myocardial Ischemia | 1 | 1993 | 263 | 0.020 |
Why?
| | Vertebral Artery | 1 | 2011 | 26 | 0.020 |
Why?
| | Endovascular Procedures | 1 | 2016 | 312 | 0.020 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2012 | 27 | 0.020 |
Why?
| | Carotid Artery Injuries | 1 | 2011 | 41 | 0.020 |
Why?
| | Blood Coagulation | 1 | 2013 | 255 | 0.020 |
Why?
| | Decision Trees | 1 | 2012 | 93 | 0.020 |
Why?
| | Fever | 1 | 2013 | 306 | 0.020 |
Why?
| | Chemokine CXCL1 | 2 | 2002 | 76 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2012 | 148 | 0.020 |
Why?
| | Lipid A | 1 | 1991 | 29 | 0.020 |
Why?
| | Pelvic Bones | 1 | 1993 | 129 | 0.020 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 1991 | 36 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 36 | 0.020 |
Why?
| | Cytokines | 1 | 1999 | 2085 | 0.020 |
Why?
| | Angiography | 1 | 2011 | 207 | 0.020 |
Why?
| | Neoplastic Syndromes, Hereditary | 1 | 2011 | 44 | 0.020 |
Why?
| | Drug Costs | 1 | 2012 | 106 | 0.020 |
Why?
| | Hospitals, University | 1 | 2011 | 182 | 0.020 |
Why?
| | Enzyme Induction | 1 | 1990 | 90 | 0.020 |
Why?
| | Pancreatic Elastase | 1 | 1990 | 58 | 0.020 |
Why?
| | Thyroid Nodule | 1 | 2011 | 56 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2012 | 271 | 0.020 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 191 | 0.020 |
Why?
| | Antioxidants | 2 | 1991 | 584 | 0.020 |
Why?
| | Survival Analysis | 2 | 2003 | 1325 | 0.020 |
Why?
| | Cyclic GMP | 2 | 1999 | 93 | 0.020 |
Why?
| | Growth Disorders | 1 | 1989 | 86 | 0.020 |
Why?
| | Reperfusion Injury | 1 | 1992 | 279 | 0.020 |
Why?
| | RNA, Messenger | 3 | 2002 | 2833 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 1991 | 220 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2011 | 270 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 591 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2002 | 2526 | 0.020 |
Why?
| | Shock, Septic | 1 | 1991 | 219 | 0.020 |
Why?
| | Liver Diseases | 1 | 1992 | 315 | 0.020 |
Why?
| | Medical Oncology | 1 | 2011 | 289 | 0.020 |
Why?
| | Fractures, Bone | 1 | 1993 | 380 | 0.020 |
Why?
| | Glutathione | 1 | 1990 | 356 | 0.020 |
Why?
| | Radiology | 1 | 2011 | 180 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2011 | 451 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 1998 | 2129 | 0.020 |
Why?
| | Thyroid Neoplasms | 1 | 2011 | 343 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 1990 | 1060 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 1992 | 623 | 0.020 |
Why?
| | Serum Albumin | 3 | 1992 | 150 | 0.020 |
Why?
| | Enzyme Inhibitors | 2 | 2000 | 840 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 2006 | 32 | 0.020 |
Why?
| | Equipment Failure | 1 | 2006 | 108 | 0.010 |
Why?
| | Arm | 1 | 2005 | 104 | 0.010 |
Why?
| | Hypertension, Renovascular | 1 | 2004 | 15 | 0.010 |
Why?
| | Hydrocephalus | 1 | 2006 | 106 | 0.010 |
Why?
| | Posture | 1 | 2005 | 185 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 352 | 0.010 |
Why?
| | Rupture | 1 | 2004 | 92 | 0.010 |
Why?
| | Subclavian Vein | 1 | 2003 | 15 | 0.010 |
Why?
| | Hemothorax | 1 | 2003 | 11 | 0.010 |
Why?
| | Abdominal Abscess | 1 | 2003 | 27 | 0.010 |
Why?
| | Jugular Veins | 1 | 2003 | 41 | 0.010 |
Why?
| | Rectovaginal Fistula | 1 | 2003 | 10 | 0.010 |
Why?
| | Appendix | 1 | 2003 | 30 | 0.010 |
Why?
| | Fetal Death | 1 | 2003 | 55 | 0.010 |
Why?
| | Gene Expression Regulation | 2 | 2004 | 2607 | 0.010 |
Why?
| | Zymosan | 1 | 2002 | 65 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2006 | 1389 | 0.010 |
Why?
| | Safety | 1 | 2004 | 338 | 0.010 |
Why?
| | Creatinine | 1 | 2004 | 499 | 0.010 |
Why?
| | Renal Insufficiency | 1 | 2004 | 162 | 0.010 |
Why?
| | Medical Errors | 1 | 2003 | 112 | 0.010 |
Why?
| | Diagnostic Errors | 1 | 2003 | 170 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2001 | 43 | 0.010 |
Why?
| | Probability | 1 | 2002 | 304 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2002 | 189 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 2002 | 269 | 0.010 |
Why?
| | Bucladesine | 1 | 2001 | 26 | 0.010 |
Why?
| | Catalase | 2 | 1992 | 130 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 87 | 0.010 |
Why?
| | Vinblastine | 2 | 1992 | 71 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 2002 | 159 | 0.010 |
Why?
| | Toll-Like Receptor 2 | 1 | 2002 | 115 | 0.010 |
Why?
| | Spine | 1 | 2003 | 173 | 0.010 |
Why?
| | Toll-Like Receptors | 1 | 2002 | 185 | 0.010 |
Why?
| | Vagina | 1 | 2003 | 187 | 0.010 |
Why?
| | Nitrites | 1 | 2001 | 84 | 0.010 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 253 | 0.010 |
Why?
| | I-kappa B Proteins | 1 | 2001 | 81 | 0.010 |
Why?
| | Nitrates | 1 | 2001 | 92 | 0.010 |
Why?
| | omega-N-Methylarginine | 1 | 2000 | 27 | 0.010 |
Why?
| | Trachea | 1 | 2002 | 237 | 0.010 |
Why?
| | Renal Dialysis | 1 | 2004 | 435 | 0.010 |
Why?
| | Guanidines | 1 | 2000 | 39 | 0.010 |
Why?
| | I-kappa B Kinase | 1 | 2000 | 55 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2000 | 88 | 0.010 |
Why?
| | Recurrence | 1 | 2003 | 1060 | 0.010 |
Why?
| | Toll-Like Receptor 4 | 1 | 2002 | 273 | 0.010 |
Why?
| | Animals, Newborn | 1 | 2002 | 844 | 0.010 |
Why?
| | Mice | 3 | 2002 | 17787 | 0.010 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2000 | 173 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2004 | 778 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 852 | 0.010 |
Why?
| | Immunoblotting | 1 | 2000 | 308 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2000 | 332 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 2002 | 405 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2002 | 652 | 0.010 |
Why?
| | Antibodies | 1 | 2001 | 410 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 2000 | 390 | 0.010 |
Why?
| | Histamine Agonists | 1 | 1998 | 1 | 0.010 |
Why?
| | Dimaprit | 1 | 1998 | 3 | 0.010 |
Why?
| | Niacinamide | 1 | 1999 | 82 | 0.010 |
Why?
| | Blood Circulation | 1 | 1998 | 41 | 0.010 |
Why?
| | Prevalence | 1 | 2005 | 2734 | 0.010 |
Why?
| | Vas Deferens | 1 | 1998 | 12 | 0.010 |
Why?
| | Benzamides | 1 | 1999 | 216 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1353 | 0.010 |
Why?
| | Adrenergic beta-Agonists | 1 | 1998 | 134 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 815 | 0.010 |
Why?
| | Placebo Effect | 1 | 1997 | 25 | 0.010 |
Why?
| | Vascular Resistance | 1 | 1998 | 375 | 0.010 |
Why?
| | Cell Movement | 1 | 2001 | 967 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2000 | 424 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1999 | 491 | 0.010 |
Why?
| | Sex Factors | 1 | 2003 | 2071 | 0.010 |
Why?
| | Intraoperative Period | 1 | 1996 | 59 | 0.010 |
Why?
| | Hospital Costs | 1 | 1997 | 117 | 0.010 |
Why?
| | Energy Metabolism | 2 | 1993 | 922 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 4193 | 0.010 |
Why?
| | Graft Rejection | 1 | 2000 | 624 | 0.010 |
Why?
| | Iothalamate Meglumine | 1 | 1996 | 4 | 0.010 |
Why?
| | Gene Expression | 1 | 2001 | 1502 | 0.010 |
Why?
| | Cholangiography | 1 | 1996 | 17 | 0.010 |
Why?
| | Gallbladder | 1 | 1996 | 19 | 0.010 |
Why?
| | Traction | 1 | 1996 | 20 | 0.010 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2000 | 351 | 0.010 |
Why?
| | Dissection | 1 | 1996 | 52 | 0.010 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 1996 | 78 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2000 | 1050 | 0.010 |
Why?
| | Single-Blind Method | 1 | 1996 | 282 | 0.010 |
Why?
| | DNA | 1 | 2001 | 1459 | 0.010 |
Why?
| | Phenethylamines | 1 | 1993 | 23 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2000 | 3015 | 0.010 |
Why?
| | Adenosine | 1 | 1994 | 225 | 0.010 |
Why?
| | Norepinephrine | 1 | 1993 | 204 | 0.010 |
Why?
| | Ibuprofen | 1 | 1992 | 84 | 0.010 |
Why?
| | Nitroblue Tetrazolium | 1 | 1991 | 12 | 0.010 |
Why?
| | Ventricular Function | 1 | 1991 | 61 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2002 | 4295 | 0.010 |
Why?
| | Tungsten | 1 | 1991 | 30 | 0.010 |
Why?
| | Chemotaxis, Leukocyte | 1 | 1991 | 136 | 0.010 |
Why?
| | Arrhythmias, Cardiac | 1 | 1993 | 333 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1991 | 150 | 0.010 |
Why?
| | Azepines | 1 | 1991 | 90 | 0.010 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 1 | 1990 | 54 | 0.010 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 1990 | 25 | 0.010 |
Why?
| | Permeability | 1 | 1991 | 161 | 0.010 |
Why?
| | Endothelium | 1 | 1991 | 123 | 0.010 |
Why?
| | Triazoles | 1 | 1991 | 147 | 0.010 |
Why?
| | Cell Adhesion | 1 | 1991 | 466 | 0.000 |
Why?
| | Kinetics | 1 | 1992 | 1670 | 0.000 |
Why?
| | Liver Transplantation | 1 | 1996 | 871 | 0.000 |
Why?
| | Biomechanical Phenomena | 1 | 1990 | 810 | 0.000 |
Why?
| | Proteins | 1 | 1991 | 1009 | 0.000 |
Why?
| | Diet | 1 | 1991 | 1278 | 0.000 |
Why?
|
|
Bensard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|